Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
COMPRESSED, N.O.S.
Overview
What is COMPRESSED, N.O.S.?
What does COMPRESSED, N.O.S. look like?
What are the available doses of COMPRESSED, N.O.S.?
Sorry No records found.
What should I talk to my health care provider before I take COMPRESSED, N.O.S.?
Sorry No records found
How should I use COMPRESSED, N.O.S.?
Sorry No records found
What interacts with COMPRESSED, N.O.S.?
Sorry No Records found
What are the warnings of COMPRESSED, N.O.S.?
Sorry No Records found
What are the precautions of COMPRESSED, N.O.S.?
Sorry No Records found
What are the side effects of COMPRESSED, N.O.S.?
Sorry No records found
What should I look out for while using COMPRESSED, N.O.S.?
What might happen if I take too much COMPRESSED, N.O.S.?
Sorry No Records found
How should I store and handle COMPRESSED, N.O.S.?
Sorry No Records found
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Non-Clinical Toxicology
Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, it should be used with caution in patients receiving such agents.Clindamycin is metabolized predominantly by CYP3A4, and to a lesser extent by CYP3A5, to the major metabolite clindamycin sulfoxide and minor metabolite N-desmethylclindamycin. Therefore inhibitors of CYP3A4 and CYP3A5 may increase plasma concentrations of clindamycin and inducers of these isoenzymes may reduce plasma concentrations of clindamycin. In the presence of strong CYP3A4 inhibitors, monitor for adverse reactions. In the presence of strong CYP3A4 inducers such as rifampicin, monitor for loss of effectiveness.
In vitro
WARNING:Administration of this mixture may be hazardout or contraindicated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Helium/Oxygen Mixtrues, who is familiar with the indications, effects, dosages, methods, frequency, and duration of administration and with the hazards, contraindications, side effects, and precations to be taken.
WARNING: CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED.
FIRST AID: IF ACCIDENTALLY INHALED:
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).